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The relationship between peak cough flow and respiratory function 
testing (spirometry), and the factors that influence this, post bilateral 
sequential single lung transplantation: a cross-sectional feasibility 
study at a single centre cardiothoracic transplantation unit 
A. M. Roberts1,2 C. L. Pereira1, M. R. Carby1, A. R. Simon1, N.S.  Drey2, A.K. Reed1 
1Royal Brompton and Harefield NHS Foundation Trust, 2City, University of London 
BACKGROUND 
•  Chronic lung allograft dysfunction (CLAD) is the leading cause of mortality 
post bilateral sequential single lung transplantation (BSSLTx)1, 2 
•  CLAD is associated with recurrent respiratory tract infections (RTI)2 
•  Adequate cough strength is the main defence mechanism against RTI4 
and this is known to be impaired post BSSLTx5 
•  Peak cough flow (PCF) is a recognised clinical predictor tool in other 
disease populations6 with normal adult PCF 440-1200 L/min7 
•  PCF ≥ 270 L/min = adequate cough. PCF ≤ 160 L/min = inefficient cough6 
AIMS 
•  To evaluate the feasibility of recruitment and conducting PCF testing 
alongside standard care 
•  To examine the relationship between PCF and spirometry: forced vital 
capacity (FVC) and forced expiratory volume in one second (FEV1) 
•  To examine other factors that influence PCF 
METHODS 
•  Baseline characteristics collected 
•  FVC and FEV1 measured by pneumotachograph on day of PCF testing  
•  Best of 3-5 PCF attempts measured with portable peak flow meter (mini 
Wright Standard Range Peak Flow Meter™ ) 
•  Health related quality of life (HRQoL) measure (EuroQol EQ-5D-5L™) 
completed 
RESULTS 
•  Study methods feasible 
•  91.90% recruitment rate, PCF test well 
tolerated 
•  n = 34 (61.8% male, 91.7% white British) 
CONCLUSION AND RECOMMENDATIONS 
•  Study methods feasible and PCF test well tolerated 
•  Positive correlation shown between PCF and spirometry (FVC and FEV1), 
even when controlling for other variables 
•  Significantly higher FVC associated with hospital LOS < 36 days 
•  PCF changed with time elapsed post BSSLTx: significant difference (p = .
007) noted between 223-972 days versus 973 – 1886 post operatively 
•  HRQoL did not appear to influence respiratory performance 
•  CLAD classification had moderate or strong negative correlations with PCF, 
FVC and FEV1 
•  CLAD severity found to be worse dependant on time elapsed post BSSLTx 
•  A larger longitudinal study needs to be carried out with an increased sample 
size (estimated to be 244), revised sampling technique and consideration of 
additional respiratory outcome measures such as respiratory muscle testing 
	
Age (years) 58.50 (17) 
Height (cm) 168.84 (11.01) 
Weight (kg) 72.02 (18.83) 
BMI kg/m2 25.12 (24.60) 
FVC (L/sec) 3.25 (1.07) 
FEV1 (L/sec) 2.66 (1.09) 
PCF (L/min) median (IQR 
25-75%) 
220 (150) 
Total hospital LOS (days) 
median (IQR 25-75%) 
35.50 (30) 
Time elapsed post BSSLTx 
(days) median (IQR 25-75%) 
972 (1692) 
EQ-5D-5L™ VAS Score 
(0-100) 
72.56 (17.23) 
EQ-5D-5L™ Value State  
(0-1) median (IQR 25-75%)  
0.82 (0.23) 
Moderate positive correlations 
(rho = .471, n = 34, p = .005) 
Significantly higher FVC (p = .024) in patients with a total 
hospital LOS ≤ 36 days compared to those > 37 days 
Significant differences in PCF as grouped into 
number of days elapsed post BSSLTx 
Moderate positive correlations 
(rho = .389, n = 34, p = .023) 
References: 
1.  Meyer, K. (2013) ‘Lung transplantation’, F1000Prime Reports, 5 16), pp. 1-10 
2.  Verleden, G., Raghu, G., Meyer, K., Glanville, A. and Corris, P. (2014) ‘A new classification system for chronic lung 
allograft dysfunction’, The Journal of Heart and Lung Transplantation, Elsevier, 33(2), pp. 127-133 
3.  Yeung, J. and Keshavjee, S. (2014) ‘Overview  of clinical lung transplantation’, Cold Spring Harbor Perspectives in 
Medicine, 4(1), pp. 1-14 
4.  Chang, A. (2006) ‘The physiology of cough’, Paediatric Respiratory Reviews, 7, pp. 2-8 
5.  Duarte, A. and Myers, A. (2012) ‘Cough Reflex in Lung Transplant Recipients’, Lung, 190, pp. 23-27 
6.  Hull, J., Aniapravan, R., Cham, E., Chatwin, M., Furton, J., Gallagher, J., Gibson, N., Gordon J., Hughes, I. and 
McCulloch, R. (2012) ‘British Thoracic Society guideline for respiratory management of children with neuromuscular 
weakness’, Thorax, 67, pp. i1-i40 
7.  Bianchi, C. and Baiardi, P. (2008) Cough Peak Flows : Standard Values for Children and Adolescents, American Journal of 
Physical Medicine and Rehabilitation, 87 (6), pp. 461–467 
CONTACT DETAILS: a.roberts@rbht.nhs.uk OR abigail.roberts@city.ac.uk 
Figure A: Best PCF (L/min) versus FVC (L/sec) Figure C: Mean FVC (L/sec) versus Total Hospital 
LOS (days) 
Figure D: Median PCF (L/min) versus Time Elapsed Post 
BSSLTx (days) 
Table 1: participant characteristics  
(mean (SD) unless otherwise stated) 
Figure B: Best PCF (L/min) versus FEV1 (L/sec) 
